The Sinaloa Cartel will likely remain the dominant trafficker of US-bound synthetic drugs through 2026 despite the ongoing internal war, given its decades-long supply-chain depth, 47-country footprint, and political-protection infrastructure inside Mexico.
Sinaloa Cartel
A Mexico-based transnational drug-trafficking and organised-crime syndicate headquartered in Culiacán, Sinaloa, designated by the United States in February 2025 as a Foreign Terrorist Organization.
Scope is the cartel as a whole — its history, factions (Los Chapitos and Los Mayos / La Mayiza), market position, geographic footprint, and current trajectory. Sister Mexican organisations (CJNG, Gulf, La Familia, Caballeros Templarios, Beltrán-Leyva remnants) and Chinese precursor suppliers are touched only where they bear directly on the cartel's situation.
Bottom Line Up Front
The Sinaloa Cartel is the largest and most established Mexican drug-trafficking organisation — the principal trafficker of US-bound fentanyl, methamphetamine, cocaine and heroin, with a DEA-assessed presence in roughly 47 countries. Since the 25 July 2024 US capture of co-founder Ismael 'El Mayo' Zambada — engineered by El Chapo's son Joaquín Guzmán López — the cartel has fractured into a hot war between Los Chapitos and Los Mayos / La Mayiza, with Sinaloa-state homicides reportedly up about 400% year-on-year. On 20 February 2025 the US State Department formally designated the cartel a Foreign Terrorist Organization, and by February 2026 the Trump White House had directed the Pentagon to prepare military force options against designated cartels; the organisation is nonetheless likely to remain dominant through 2026, given its supply-chain depth and embedded political protection in Sinaloa.
What it is
The Sinaloa Cartel (Cártel de Sinaloa, CDS) is a transnational organised-crime syndicate that emerged c. 1989 from the splintering of the Guadalajara Cartel after the arrest of Miguel Ángel Félix Gallardo. It is variously described by InSight Crime as 'the largest and most powerful drug trafficking organization in the Western Hemisphere' [ev_024] and by Wikipedia as 'Mexico's most dominant drug cartel since the 1990s' [ev_001]. Its core business is wholesale trafficking of fentanyl, methamphetamine, cocaine, heroin and cannabis into the United States, with secondary lines in money laundering, extortion and contract violence [ev_001, ev_021, ev_033]. Functionally, the 'cartel' is best understood as a federation of allied trafficking families — historically dominated by the Guzmán-Loera and Zambada-García lineages — rather than a tightly hierarchical firm. Since mid-2024 that federation has split into two warring factions: Los Chapitos under Iván Archivaldo Guzmán Salazar, and Los Mayos / La Mayiza under Ismael Zambada Sicairos [ev_004, ev_009, ev_010].
Who operates in it
Two founding families have run the cartel for three decades: the Guzmán-Loera line, anchored by Joaquín 'El Chapo' Guzmán (born 1957, life sentence in US federal prison since 2019 [ev_002]), and the Zambada-García line, anchored by Ismael 'El Mayo' Zambada (born 1948, in US custody since 25 July 2024 [ev_003, ev_005]). The current generation of co-leaders is Iván Archivaldo Guzmán Salazar ('El Chapito') for Los Chapitos and Ismael Zambada Sicairos for Los Mayos [ev_004]. Two of El Chapo's sons — Ovidio Guzmán López and Joaquín Guzmán López — are in US custody [ev_006, ev_019]; the latter is widely reported to have lured El Mayo onto a Texas-bound flight, triggering the current civil war [ev_005, ev_019, ev_013]. The relevant counter-actors are the US Departments of State (FTO designation) [ev_014, ev_015], Treasury / OFAC (financial sanctions) [ev_017, ev_018, ev_027] and the DEA (enforcement and threat assessment) [ev_021, ev_023]; on the Mexican side, the Sheinbaum administration is the principal political-military respondent. The cartel's main external rival is the Cartel Jalisco Nueva Generación (CJNG), co-designated an FTO in February 2025 [ev_014, ev_022, ev_029].
How it works
Operationally the cartel runs an end-to-end supply chain: precursor procurement (chiefly from PRC-based brokers for fentanyl and methamphetamine), wholesale lab production in Sinaloa and adjacent states, transport via aircraft, narcosubs, container ships, fishing vessels, go-fast boats, buses, rail cars, tractor-trailers and automobiles into US distribution networks [ev_003], and laundering through cash businesses, bulk currency smuggling, trade-based laundering and increasingly cryptocurrency (the May 2026 OFAC action explicitly named six Ethereum addresses in a cartel-linked laundering network) [ev_027]. Governance is enforced through targeted violence — kidnappings, extortion and murder of rivals and journalists [ev_033]. Inter-faction conflict (Los Chapitos vs Los Mayos) is fought in Sinaloa-state cities through ambushes, vehicle attacks and territorial denial that have killed thousands since mid-2024 [ev_009, ev_010, ev_026]. Externally, the cartel competes with CJNG for plazas and route control, while cooperating selectively with foreign brokers in the Asia-Pacific and with smaller regional outfits as franchisees [ev_022, ev_029].
Why it exists
The cartel exists because demand for opioids, stimulants and cocaine in the United States has remained durable and price-inelastic for over four decades; because Mexico provides the geographic, political and legal conditions in which a vertically-integrated narco-business can be defended against rivals and the state; and because the synthetic-drug shift after 2015 collapsed the cost of producing high-margin product (fentanyl, methamphetamine) using imported precursors, multiplying margins relative to plant-based drugs [ev_021, ev_022, ev_030]. The cartel's resilience is sustained by transactional embedded protection inside Sinaloa state institutions — described by the NYT in May 2026 as a structure in which 'in exchange for bribes and political support [cartel insiders] were allowed to operate in Sinaloa state with near total freedom' [ev_031] — and by a federated family structure that distributes risk across multiple plazas and supply lines.
When — the chronology
The cartel's lineage runs from the 1980s Guadalajara Cartel of Miguel Ángel Félix Gallardo, whose 1989 arrest dispersed his organisation into regional successor groups including the Sinaloa Cartel [ev_008]. The El Chapo era began in earnest in the 1990s and ran until his 2014 arrest, 2015 escape, 2016 re-capture, 2017 extradition to the US, and 2019 life sentence [ev_002]. The October 2019 Battle of Culiacán (Culiacanazo) — in which cartel gunmen forced the Mexican state to release Ovidio Guzmán — is widely treated as the moment Sinaloa state demonstrated cartel parity with the federal government [ev_007]. The current inflection began on 25 July 2024, when Joaquín Guzmán López lured El Mayo onto a Texas-bound flight, triggering both men's US arrest and the year-long internal war that has driven Sinaloa homicides up roughly 400% year-on-year [ev_005, ev_019, ev_026]. The US legal terrain shifted on 20 January 2025 with Trump's EO directing FTO designation [ev_016] and on 20 February 2025 with the State Department's formal listing of the cartel as an FTO/SDGT [ev_014, ev_015]; military-force options were ordered prepared in February 2026 [ev_028]. The cartel remains operationally active in mid-2026, with Mexican military hits (Omar Oswaldo Torres detained 19 March 2026) and fresh OFAC sanctions on its fentanyl supply chain (20 May 2026) continuing [ev_032, ev_027].
Where
The cartel is headquartered in Culiacán, Sinaloa, Mexico (24.807°N, 107.394°W) [ev_011, ev_012], with operational dominance across Sinaloa state and contested presence in Sonora, Chihuahua, Baja California, Durango, Nayarit and Jalisco. The DEA's 2024 National Drug Threat Assessment characterises its footprint as 'at least 47 countries' [ev_023]; Wikipedia's standing description names operations in 'the United States, Latin America, and as far as the Philippines' [ev_001]. Brookings characterises the cartel as the Mexican organisation that 'pioneered expansion into Asia-Pacific' [ev_022]. The principal consumer market is the United States; Chinese chemical-precursor supply is a critical upstream node for fentanyl and methamphetamine production [ev_022].
Players
14 in the space- Joaquín 'El Chapo' Guzmán co-founder; symbolic patriarch of Los Chapitos faction Incarcerated for life in US federal prison.
- Ismael 'El Mayo' Zambada co-founder; symbolic patriarch of Los Mayos faction In US federal custody since 25 July 2024.
- Iván Archivaldo Guzmán Salazar current co-leader of Sinaloa Cartel; Los Chapitos faction head
- Ismael Zambada Sicairos ('El Mayito Flaco') current co-leader of Sinaloa Cartel; Los Mayos faction head
- Joaquín Guzmán López Los Chapitos member; orchestrated El Mayo's delivery to US authorities
- Ovidio Guzmán López former Los Chapitos leader; extradited to US 2023
- Los Chapitos internal faction; principal driver of cartel's fentanyl operations per DEA
- Los Mayos / La Mayiza internal faction warring with Los Chapitos since July 2024
- Cartel Jalisco Nueva Generación (CJNG) principal external rival; co-designated FTO Feb 2025
- Guadalajara Cartel predecessor organisation (1980s)
- US Department of State regulator (FTO/SDGT designation 20 Feb 2025)
- US Treasury / OFAC regulator (SDN listings; fentanyl-chain sanctions 2025–2026)
- US DEA enforcement; publishes NDTA assessing 47-country footprint
- Omar Oswaldo Torres reported Los Mayos leader; detained 19 Mar 2026 in Mexican military raid
Chronology
14 events- 1989-04-08 Arrest of Miguel Ángel Félix Gallardo precipitates the breakup of the Guadalajara Cartel; successor groups including the Sinaloa Cartel emerge in the following years.
- 2014-02-22 Joaquín 'El Chapo' Guzmán arrested by Mexican Marines in Mazatlán.
- 2016-01-08 El Chapo recaptured following his 2015 prison escape; subsequently extradited to the United States in January 2017.
- 2019-07-17 El Chapo sentenced to life plus 30 years in US federal court, Brooklyn.
- 2019-10-17 Battle of Culiacán (Culiacanazo / Black Thursday): cartel gunmen force the Mexican government to release Ovidio Guzmán López after his initial capture.
- 2023-09-15 Ovidio Guzmán López extradited to the United States to face drug-trafficking charges.
- 2024-07-25 Ismael 'El Mayo' Zambada and Joaquín Guzmán López arrested at a small airport near El Paso, Texas; multiple US-government sources later state Guzmán López duped Zambada onto the flight.
- 2025-01-20 President Trump signs Executive Order 14157 directing the Secretary of State to designate international criminal organizations including the Sinaloa Cartel as FTOs / SDGTs.
- 2025-02-20 State Department formally designates the Sinaloa Cartel, CJNG, and six other organizations as Foreign Terrorist Organizations; published in the Federal Register.
- 2025-08-18 CNN reports homicides in Sinaloa state up roughly 400% year-on-year since El Mayo's capture; year-long Los Chapitos vs Los Mayos war characterised as one of the worst cartel battles on record.
- 2026-02-11 President Trump directs the Pentagon to prepare military options for possible use of force against cartels designated as terrorist organizations.
- 2026-03-19 Mexican military raid targeting Sinaloa Cartel leader; Omar Oswaldo Torres (reported Los Mayos leader) detained; 11 killed.
- 2026-05-15 NYT publishes account by cartel insiders alleging deep, transactional protection arrangements between the Sinaloa Cartel and Sinaloa-state officials.
- 2026-05-20 OFAC sanctions 11 individuals and 2 entities tied to the Sinaloa Cartel's fentanyl supply chain, including six Ethereum addresses; coordinated with Mexico's Unidad de Inteligencia Financiera.
Market
The relevant market is the US illicit-drug retail market, principally fentanyl, methamphetamine, cocaine and heroin. The DEA characterises the cartel as one of the two organisations (with CJNG) that dominate the US supply, and assesses that 'Los Chapitos and the Sinaloa Cartel reap billions of dollars in profits from the fentanyl trade' [ev_021]. Wikipedia cites a US market value 'as of 2021' of up to roughly $50 billion across all illicit drugs (not cartel revenue) and Mexican government estimates have historically cited annual Sinaloa-specific earnings near $3 billion. Older $40 billion figures circulated by US officials in 2010 were widely understood by 2025 to conflate cartel revenue with broader Mexican-drug-trade gross. Concentration in the cartel's principal market is bipolar (Sinaloa Cartel / CJNG) with declining concentration at the margin as the post-2024 fragmentation opens space for smaller regional outfits [ev_010, ev_029]. The most consequential dynamic is the shift from plant-based to synthetic drugs (fentanyl, methamphetamine) which has expanded both margins and US public-health damage; the cartel pioneered that shift but is now vulnerable to enforcement attacks on its precursor supply chains and to OFAC's increasing fluency at sanctioning the laundering infrastructure [ev_021, ev_022, ev_027].
- Size
- Per DEA NDTA 2024, the Sinaloa Cartel and Los Chapitos earn 'billions of dollars in profits' from fentanyl alone [ev_021]; older Mexican-government estimates put Sinaloa-specific annual earnings near $3 billion (CRS, c. 2012) [ev_001]; older DEA-cited $40 billion figures (2010-vintage) likely reflect the wider Mexican drug-trade gross, not cartel revenue.
- Segments
- Fentanyl and other synthetic opioids (current primary revenue driver) · Methamphetamine (synthetic, high-margin) · Cocaine (transhipment + wholesale to US) · Heroin (declining as fentanyl substitutes) · Cannabis (legacy line, eroded by US state legalisation) · Service lines: contract violence, extortion, money laundering
- Dynamics
- Three dynamics dominate 2024–2026: (1) internal fragmentation — Los Chapitos vs Los Mayos war is bleeding Sinaloa state and forcing both factions to spend on conflict rather than expansion [ev_009, ev_010, ev_026]; (2) regulatory escalation — US FTO/SDGT designation (Feb 2025), Pentagon force-option planning (Feb 2026) and accelerated OFAC sanctioning of the fentanyl chain (2025–2026) [ev_014, ev_015, ev_028, ev_027]; (3) market substitution — the synthetic-opioids transition has fattened margins but is now exposed to upstream interdiction of Chinese precursor supply and to US public-health responses (naloxone deployment, treatment scale-up) [ev_021, ev_022].
Outlook
Moderate confidenceThrough end-2026 the Sinaloa Cartel will likely remain the dominant Mexican trafficker of US-bound synthetic drugs, even as the Los Chapitos vs Los Mayos war continues to depress its short-term operational tempo and territorial coherence. A clean victory by either faction is unlikely in the coming year; a Los Mayos consolidation is roughly an even chance over a 12–24 month horizon if Mexican enforcement (e.g. the 19 March 2026 detention of Omar Oswaldo Torres) and US pressure continue to fall disproportionately on Los Chapitos. The February 2025 FTO designation, May 2026 OFAC fentanyl-chain sanctions, and February 2026 Pentagon force-option order have meaningfully changed the legal terrain, but unilateral US military action inside Mexico remains unlikely on a 12-month horizon given Sheinbaum-administration resistance, USMCA-trade exposure, and the political cost. Without sustained, structural Mexican action against the political protection networks documented by the NYT in May 2026, even successful US interdictions are unlikely to dismantle the cartel. CJNG and smaller successor groups will likely make incremental territorial gains at the cartel's margins.
Key Judgments
graded per ICD 203The Los Chapitos–Los Mayos war is roughly evenly balanced as of mid-2026 and is unlikely to end through a single decisive military victory; ACLED, El País, and Crashout Media independently report that neither faction holds clear territorial dominance and that fragmentation is opening space for outside groups (CJNG, smaller regional outfits) to encroach.
The February 2025 US FTO/SDGT designation has materially changed the legal terrain — opening civil-forfeiture, material-support, and (per White House and ABC reporting) Pentagon force-option authorities against the cartel — but on its own is unlikely to dismantle the organization without sustained Mexican enforcement against political protectors.
The cartel's revenue is principally fentanyl-driven as of 2024–2026, with DEA assessing 'billions in profits' from synthetic opioids and Treasury sanctioning Sinaloa-linked precursor supply chains; older $3 billion / $40 billion estimates remain contested and likely conflate cartel revenue with broader Mexican drug-trade gross.